表 3.
入组患者输尿管支架相关症状分项评分
Results of ureteral stent symptoms questionnaire (USSQ) sub-score of the patients
Items | Control Group | Delayed ureteral sent removal group | P |
USSQ urinary symptom score | |||
U1-daytime frequency, M(P25, P75) | 2 (1, 2) | 3 (2, 3) | < 0.001 |
U2-nocturia, x±s | 2.23±0.88 | 2.33±0.59 | 0.555 |
U3-urgency, M(P25, P75) | 1 (1, 2) | 2 (1, 2) | 0.001 |
U4-straining to start, M(P25, P75) | 1 (1, 2) | 2 (1, 2) | 0.002 |
U5-urge incontinence, x±s | 1.20±0.41 | 1.33±0.48 | 0.209 |
U6-residual urine sense, M(P25, P75) | 2 (1, 2) | 3 (3, 4) | < 0.001 |
U7-dysuria, x±s | 2.03±0.71 | 2.31±0.62 | 0.084 |
U8-hematuria rate, M(P25, P75) | 2 (1, 2) | 2 (2, 3) | 0.016 |
U9-hematuria amount, M(P25, P75) | 2 (1, 2) | 2 (2, 2) | 0.034 |
U10-total symptom, M(P25, P75) | 1 (1, 2) | 2 (2, 3) | < 0.001 |
U11-intention of long-term indwelling stent, M(P25, P75) | 3 (3, 3) | 4 (3, 4) | < 0.001 |
USSQ physical pain score | |||
P1-presence of pain, n(%) | 4 (11.4) | 10 (27.8) | 0.083 |
P2-presence of upper abdominal pain, n(%) | 0 (0) | 0 (0) | - |
P3-SPDS of upper abdominal pain | 0 | 0 | - |
P2-presence of lower abdominal pain, n(%) | 0 (0) | 5 (13.9) | 0.054 |
P3-SPDS of lower abdominal pain | 0 | 0.39±1.05 | 0.033 |
P2-presence of suprapubic pain, n(%) | 0 (0) | 0 (0) | - |
P3-SPDS of suprapubic pain | 0 | 0 | - |
P2-presence of back pain, n(%) | 3 (8.6) | 9 (25) | 0.065 |
P3-SPDS of back pain, x±s | 0.23±0.81 | 0.83±1.54 | 0.042 |
P2-presence of penis pain, n(%) | 1 (2.9) | 0 (0) | 0.493 |
P3-SPDS of penis pain, x±s | 0.11±0.68 | 0 | 0.324 |
P4-physical activity, x±s | 1.20±0.41 | 1.47±0.81 | 0.078 |
P5-sleep difficulty, M(P25, P75) | 1 (1, 1) | 1 (1, 2) | 0.024 |
P6-pain during voiding, M(P25, P75) | 2 (2, 3) | 1 (1, 2) | 0.002 |
P7-flank pain during voiding, x±s | 1.51±0.51 | 1.44±0.50 | 0.562 |
P8-analgesics, x±s | 1.20±0.41 | 1.31±0.58 | 0.377 |
P9-effects of stent-related pain, x±s | 1.40±0.55 | 1.61±1.13 | 0.319 |
USSQ general health score | |||
G1-light physical activities | 1 | 1 | - |
G2-heavy physical activities, M(P25, P75) | 3 (2, 3) | 4 (3, 4) | < 0.001 |
G3-tiredness and fatigue, M(P25, P75) | 1 (1, 2) | 2 (2, 2) | < 0.001 |
G4-calm and tranquility, M(P25, P75) | 1 (1, 2) | 3 (3, 4) | < 0.001 |
G5-social activities, M(P25, P75) | 1 (1, 2) | 4 (3, 4) | < 0.001 |
G6-extra help from relatives and friends, x±s | 1.60±0.50 | 1.72±0.45 | 0.284 |
USSQ work performance score, M(P25, P75) | |||
W5-shorten working hours | 1 (1, 1) | 2 (2, 2) | < 0.001 |
W6-change the usual job | 1 (1, 2) | 2 (1, 2) | 0.002 |
W7-working hours | 2 (1, 3) | 4 (3.75, 4) | < 0.001 |
USSQ sexual function score, x±s | |||
S4-dyspareunia | 1.23±0.43 | 1.17±0.38 | 0.519 |
S5-sexual life | 2.74±0.51 | 2.94±0.23 | 0.037 |
USSQ ureteral stent related infection score | |||
I1-urinary tract infection frequency, M(P25, P75) | 1 (1, 2) | 2 (2, 3) | < 0.001 |
I2-antibiotic use, M(P25, P75) | 1 (1, 1) | 1 (1, 2) | < 0.001 |
I3-extra help from medical staff, x±s | 1.14±0.36 | 1.25±0.44 | 0.262 |
I4-seek medical attention, M(P25, P75) | 1 (1, 1) | 1 (1, 1) | 0.006 |
I5-intention to indwell the second stent on the opposite side, M(P25, P75) | 3 (3, 4) | 4 (4, 4) | < 0.001 |